Hubertus von Baumbach | Son of Erich von Baumbach – Boehringer Ingelheim

Net worth: $42.2 billion

Hubertus von Baumbach was born in 1966 to Erich von Baumbach and Ulrike Boehringer. Through his mother, he is a great-grandson of Albert Boehringer, founder of the German pharmaceutical giant Boehringer Ingelheim in 1885. He graduated from MIT with a degree in law and a master of business administration. In 2001, he worked in Boehringer Ingelheim and became CEO of the company in 2016. Under his tenure, the company made a massive asset swap deal with French pharmaceutical company Sanofi worth more than $20 billion. It made Boehringer Ingelheim a big player in animal healthcare. He also oversaw record profits for the company, with an estimated $23 billion in profits in 2019.

Outside of Boehringer Ingelheim, Hubertus is also a member of advisory boards in several banks, most notably Deutsche Bank. He is also the head of several foundations, including the Federation of German Industries between 2018 and 2019 and Stiftung Tausendgut, a foundation focused on helping disabled people. He is also a patron of the arts and a member of the Städel Museum’s Board of Trustees. The net worth of von Baumbach and his family estimates at $42.2 billion as of 2019.